Pro Medicus Limited (ASX:PME) is a Melbourne-based software owner and developer, licensing products to large US hospitals and Australian radiology clinics. The company has offices in Richmond, Victoria, Berlin, Germany and in the United States.
There are some really great ASX shares that investors can pick from. They could be candidates for a growth watchlist, like Xero Limited (ASX:XRO).
The share price of Pro Medicus Limited (ASX: PME) and Xero Limited (ASX: XRO) survived the pandemic and then thrived. How did these two ASX shares flourish in such trying times?
The Pro Medicus Ltd (ASX:PME) share price is being supported today by the University of Vermont Health Network $14 million contract win.
Learning from the past can help build a better future. Why have Pro Medicus Limited (ASX: PME) and Xero Limited (ASX: XRO) done so well?
Do you like investing in ASX small cap shares? As much as I like researching ASX dividend shares like Coles Group (ASX: COL) or Wesfarmers Ltd (ASX: WES), I love the Wild West of the ASX — small-cap growth shares.
4D Medical Ltd (ASX: 4DX) shares have resumed trading on the ASX today after being placed in a trading halt yesterday when the company announced a material grant and a subsequent capital raise. Here’s my take.
The Pro Medicus Ltd (ASX:PME) share price has regained some of the lost ground, it’s now only down 3% after the FY21 half-year report.
The Pro Medicus Ltd (ASX:PME) share price has been whacked 8% this morning after it released its FY21 half-year result.
The Pro Medicus Ltd (ASX:PME) share price went down 3% despite announcing a new contract win.
